Phibro Animal Health Corp. (NASDAQ:PAHC) saw an uptick in trading volume on Thursday . 146,197 shares changed hands during trading, a decline of 3% from the previous session’s volume of 151,029 shares.The stock last traded at $20.98 and had previously closed at $20.65.

Several research firms have commented on PAHC. Guggenheim reiterated a “buy” rating and set a $26.00 price objective (down from $34.00) on shares of Phibro Animal Health Corp. in a research note on Friday, May 13th. Zacks Investment Research lowered Phibro Animal Health Corp. from a “hold” rating to a “sell” rating in a research note on Thursday, May 12th. Morgan Stanley reiterated a “sell” rating on shares of Phibro Animal Health Corp. in a research note on Thursday, May 12th. Credit Suisse Group AG reiterated a “buy” rating and set a $42.00 price objective on shares of Phibro Animal Health Corp. in a research note on Monday, April 11th. Finally, Macquarie reiterated a “hold” rating on shares of Phibro Animal Health Corp. in a research note on Tuesday, April 19th. Three equities research analysts have rated the stock with a sell rating, two have assigned a hold rating and three have given a buy rating to the stock. The company currently has a consensus rating of “Hold” and a consensus price target of $35.33.

The firm has a 50-day moving average of $19.52 and a 200 day moving average of $24.23. The company has a market cap of $800.75 million and a price-to-earnings ratio of 10.42.

Phibro Animal Health Corp. (NASDAQ:PAHC) last announced its earnings results on Monday, May 9th. The company reported $0.38 earnings per share for the quarter, missing the consensus estimate of $0.43 by $0.05. The firm had revenue of $183 million for the quarter, compared to analyst estimates of $197.24 million. The business’s revenue for the quarter was down 2.1% on a year-over-year basis. During the same period last year, the business earned $0.41 EPS. On average, equities analysts predict that Phibro Animal Health Corp. will post $1.60 earnings per share for the current year.

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, June 22nd. Investors of record on Wednesday, June 1st were given a $0.10 dividend. The ex-dividend date was Friday, May 27th. This represents a $0.40 dividend on an annualized basis and a yield of 1.97%.

In other news, Director E Thomas Corcoran acquired 5,000 shares of Phibro Animal Health Corp. stock in a transaction that occurred on Thursday, May 19th. The stock was purchased at an average price of $18.14 per share, for a total transaction of $90,700.00. Following the completion of the transaction, the director now directly owns 10,000 shares in the company, valued at $181,400. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.

A number of large investors have recently made changes to their positions in the stock. Russell Frank Co increased its stake in shares of Phibro Animal Health Corp. by 256.6% in the fourth quarter. Russell Frank Co now owns 34,144 shares of the company’s stock worth $1,049,000 after buying an additional 24,568 shares during the last quarter. Cornerstone Capital Management Holdings LLC. increased its stake in shares of Phibro Animal Health Corp. by 95.6% in the fourth quarter. Cornerstone Capital Management Holdings LLC. now owns 87,620 shares of the company’s stock worth $2,640,000 after buying an additional 42,820 shares during the last quarter. Dimensional Fund Advisors LP increased its stake in shares of Phibro Animal Health Corp. by 92.6% in the fourth quarter. Dimensional Fund Advisors LP now owns 269,740 shares of the company’s stock worth $8,128,000 after buying an additional 129,660 shares during the last quarter. Finally, Foresters Investment Management Company Inc. increased its stake in shares of Phibro Animal Health Corp. by 8.4% in the fourth quarter. Foresters Investment Management Company Inc. now owns 953,775 shares of the company’s stock worth $28,737,000 after buying an additional 74,100 shares during the last quarter.

Phibro Animal Health Corporation is an animal health and mineral nutrition company. The Company is engaged in developing, manufacturing and marketing products for a range of food animals, including poultry, swine, beef and dairy cattle, and aquaculture. The Company operates through three segments: Animal Health, Mineral Nutrition and Performance Products.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.